L

Lytix Biopharma AS
OSE:LYTIX

Watchlist Manager
Lytix Biopharma AS
OSE:LYTIX
Watchlist
Price: 6.88 NOK 0.88% Market Closed
Market Cap: 341.3m NOK
Have any thoughts about
Lytix Biopharma AS?
Write Note

Lytix Biopharma AS
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Lytix Biopharma AS
Operating Income Peer Comparison

Comparables:
HBC
B
BGBIO
AZT
N
NYKD
T
TRMED

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
L
Lytix Biopharma AS
OSE:LYTIX
Operating Income
-kr96.8m
CAGR 3-Years
-32%
CAGR 5-Years
-9%
CAGR 10-Years
N/A
Hofseth Biocare ASA
OSE:HBC
Operating Income
-kr120.4m
CAGR 3-Years
-4%
CAGR 5-Years
-11%
CAGR 10-Years
-14%
B
Bergenbio ASA
OSE:BGBIO
Operating Income
-kr162.2m
CAGR 3-Years
20%
CAGR 5-Years
3%
CAGR 10-Years
N/A
Arcticzymes Technologies ASA
OSE:AZT
Operating Income
kr7.9m
CAGR 3-Years
-43%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
N
Nykode Therapeutics ASA
OSE:NYKD
Operating Income
-$58.9m
CAGR 3-Years
N/A
CAGR 5-Years
-64%
CAGR 10-Years
N/A
T
Thor Medical ASA
OSE:TRMED
Operating Income
-kr20.3m
CAGR 3-Years
63%
CAGR 5-Years
44%
CAGR 10-Years
7%

See Also

What is Lytix Biopharma AS's Operating Income?
Operating Income
-96.8m NOK

Based on the financial report for Dec 31, 2023, Lytix Biopharma AS's Operating Income amounts to -96.8m NOK.

What is Lytix Biopharma AS's Operating Income growth rate?
Operating Income CAGR 5Y
-9%

Over the last year, the Operating Income growth was -47%. The average annual Operating Income growth rates for Lytix Biopharma AS have been -32% over the past three years , -9% over the past five years .

Back to Top